The {pharmaceutical industry is currently exploring novel treatment methods for obesity , and the emergence of semaglutide 10mg injectables represents a change. Healthcare providers are now consider the possible benefits and challenges associated with this higher potency formulation , especially in comparison to existing lower-dose semaglutide medi